Tiba Aynechi is a PhD scientist-turned-investor who earned her biochemistry doctorate from UCSF, conducted computational biology research at Stanford, and worked as a bench scientist before transitioning through biotech banking at firms like Lehman Brothers into venture capital. She spent her entire career in the Bay Area life sciences ecosystem and over a decade as a Partner at Novo Ventures before joining Norwest, where she focuses on early to mid-stage therapeutics companies and emphasizes partnering closely with scientist founders as a peer who can speak their technical language. Tiba Aynechi is a PhD scientist-turned-investor who earned her biochemistry doctorate from UCSF, conducted computational biology research at Stanford, and worked as a bench scientist before transitioning through biotech banking at firms like Lehman Brothers into venture capital. She spent her entire career in the Bay Area life sciences ecosystem and over a decade as a Partner at Novo Ventures before joining Norwest, where she focuses on early to mid-stage therapeutics companies and emphasizes partnering closely with scientist founders as a peer who can speak their technical language.